You are requesting information on: Catalent Invests 130 Million to Add Additional Manufacturing Capacity at its Gene Therapy Campus in Harmans Maryland Catalent
Already a member of Bioprocess Online or VertMarkets? Sign in now.
In order for our suppliers to better serve your request, please enter specific requirements or questions below: